Everolimus is effective across diverse patients with GI neuroendocrine tumors
20/01/2016 - 18:52
Everolimus improves outcomes in patients with advanced, progressive neuroendocrine tumors of gastrointestinal (GI) or unknown origin regardless of pri... More »
